Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Merchavia invest in Aura Smart Air, a company that deals with purification and air quality management using artificial intelligence technology

In a joint trial of Aura Smart Air and Sheba Medical Center, preliminary results showed that Aura's solution succeeded in eliminating COVID-19 by 99.9%

A total of $3 Million will be invested at a $10 Million valuation


News provided by

Merchavia Holdings and Investments

05 Aug, 2020, 15:00 IDT

Share this article

Share toX

Share this article

Share toX

RAMAT GAN, Israel, Aug. 5, 2020 /PRNewswire/ -- Merchavia Holdings and Investments Ltd. (TASE: MRHL) has signed a Memorandum of Understanding (MoU) for its first investment in the Aura Smart Air, a company that deals with purification and air quality management using artificial intelligence technology. According to the MoU, Merchavia will invest $250,000 and will receive preference shares, which constitute approximately 1.93% of Aura Air's issued and fully diluted capital for its investment. Merchavia's investment will be made at a $10 Million valuation and is a part of an $3 Million financing round.

In experiments on COVID-19 that Aura Air conducted and is conducting with Sheba Medical Center, preliminary results showed that Aura's solution succeeded in eliminating COVID-19 by 99.9%

Aura Air is an Israeli company that has developed a platform for managing air quality in enclosed spaces through three phases: monitoring, analysis and air purification. The system monitors in real time the presence of airborne particles and gases inside and outside, and performs purification and disinfection of viruses, molds, bacteria and fungi using four dedicated patented filters. Aura Air recently completed pilots in office towers, hotels, residential buildings, and buses in the United States and other countries around the globe. The company also began a pilot designed to aid return to school routine in Israel by installing the system in classrooms.

In addition, the MoU stipulates that the companies will work to sign a marketing and distribution agreement under which Merchavia will be given the right to distribute and market the system in Cyprus and Greece for a period to be determined under the binding agreement. Completion of negotiations and signing of the binding agreement will be made within 30 days of signing the MoU.

Contact:
Eli Arad 
[email protected]

SOURCE Merchavia Holdings and Investments

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.